These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25146483)

  • 81. Interactions of protein antigens with antibodies.
    Davies DR; Cohen GH
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):7-12. PubMed ID: 8552677
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Unravelling viral camouflage: approaches to the study and characterization of conformational epitopes.
    Augustin T; Cehlar O; Skrabana R; Majerova P; Hanes J
    Acta Virol; 2015 Jun; 59(2):103-16. PubMed ID: 26104327
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A hybridoma cell line secreting antibody to poliovirus type 3 D-antigen: detection in virus harvest of two D-antigen populations.
    Ferguson M; Schild GC; Minor PD; Yates PJ; Spitz M
    J Gen Virol; 1981 Jun; 54(Pt 2):437-42. PubMed ID: 6270261
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis.
    Wiegers K; Dernick R
    J Virol; 1992 Jul; 66(7):4597-600. PubMed ID: 1376371
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20.
    McCraw DM; O'Donnell JK; Taylor KA; Stagg SM; Chapman MS
    Virology; 2012 Sep 15-30; 431(1-2):40-9. PubMed ID: 22682774
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of binding epitope of a monoclonal antibody (Z12) against human TNF-alpha using computer modeling and deletion mutant technique.
    Zhang W; Feng J; Shen B
    Sci China C Life Sci; 2004 Jun; 47(3):279-86. PubMed ID: 15524285
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Rapid structural characterization of human antibody-antigen complexes through experimentally validated computational docking.
    Simonelli L; Beltramello M; Yudina Z; Macagno A; Calzolai L; Varani L
    J Mol Biol; 2010 Mar; 396(5):1491-507. PubMed ID: 20053355
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis.
    Chen Z; Chumakov K; Dragunsky E; Kouiavskaia D; Makiya M; Neverov A; Rezapkin G; Sebrell A; Purcell R
    J Virol; 2011 May; 85(9):4354-62. PubMed ID: 21345966
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor.
    Chen Z; Fischer ER; Kouiavskaia D; Hansen BT; Ludtke SJ; Bidzhieva B; Makiya M; Agulto L; Purcell RH; Chumakov K
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20242-7. PubMed ID: 24277851
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.
    Li Q; Yafal AG; Lee YM; Hogle J; Chow M
    J Virol; 1994 Jun; 68(6):3965-70. PubMed ID: 7514682
    [TBL] [Abstract][Full Text] [Related]  

  • 91. NEP: web server for epitope prediction based on antibody neutralization of viral strains with diverse sequences.
    Chuang GY; Liou D; Kwong PD; Georgiev IS
    Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W64-71. PubMed ID: 24782517
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The antigenic structure of poliovirus.
    Hogle JM; Filman DJ
    Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):467-78. PubMed ID: 2569204
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Creation of an antigenic site in poliovirus type 1 by assembly of 14 S subunits.
    Rombaut B; Boeyé A; Ferguson M; Minor PD; Mosser A; Rueckert R
    Virology; 1990 Jan; 174(1):305-7. PubMed ID: 1688474
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cryo-EM Studies of Virus-Antibody Immune Complexes.
    Li N; Li Z; Fu Y; Cao S
    Virol Sin; 2020 Feb; 35(1):1-13. PubMed ID: 31916022
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Structural analysis of a protective epitope of the Francisella tularensis O-polysaccharide.
    Rynkiewicz MJ; Lu Z; Hui JH; Sharon J; Seaton BA
    Biochemistry; 2012 Jul; 51(28):5684-94. PubMed ID: 22747335
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding.
    Conway JF; Watts NR; Belnap DM; Cheng N; Stahl SJ; Wingfield PT; Steven AC
    J Virol; 2003 Jun; 77(11):6466-73. PubMed ID: 12743303
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antibodies to poliovirus detected by immunoradiometric assay with a monoclonal antibody.
    Spitz M; Fossati CA; Schild GC; Spitz L; Brasher M
    J Virol Methods; 1982 Oct; 5(2):101-11. PubMed ID: 6296172
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antigenic variation of poliovirus studied by means of monoclonal antibodies.
    Crainic R; Blondel B; Horaud F
    Rev Infect Dis; 1984; 6 Suppl 2():S535-9. PubMed ID: 6204369
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Reactivity of neutralizing antibodies with different specificities to H particles of poliovirus.
    Urasawa T; Urasawa S; Taniguchi K
    Microbiol Immunol; 1979; 23(7):651-7. PubMed ID: 228166
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.
    Icenogle J; Shiwen H; Duke G; Gilbert S; Rueckert R; Anderegg J
    Virology; 1983 Jun; 127(2):412-25. PubMed ID: 6306918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.